What was the nature of the 23,739-share grant to Healthpeak’s director?

The 23,739 shares reported for Thomas John T represent restricted stock units granted on February 6, 2026 at a stated price of $0. A footnote notes these RSUs vest in full on the anniversary of the February 6, 2026 grant date, reflecting standard director equity compensation.

Healthpeak director granted 23,739 RSUs, withholds shares

Healthpeak Properties, Inc. director Thomas John T reported routine equity compensation and related tax withholding transactions.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Healthpeak Properties, Inc. director Thomas John T reported routine equity compensation and related tax withholding transactions. On February 6, 2026, he received 23,739 shares of common stock as an award with a reported price of $0, increasing his directly held stake to 835,122 shares. A footnote explains these are restricted stock units that vest in full on the anniversary of the February 6, 2026 grant date.

On February 7, 2026, 6,454 shares were forfeited at $16.85 per share to satisfy tax withholding obligations tied to vesting of restricted stock units granted on February 7, 2025, leaving 828,668 common shares held directly. He also reports 58 shares held indirectly "By Child 7." The forfeiture is explicitly described as not constituting a sale transaction.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Thomas John T

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	6,454	$16.85	$109K
Grant/Award	Common Stock	23,739	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 828,668 shares (Direct); Common Stock — 58 shares (Indirect, By Child 7)

Footnotes (2)

F1. Restricted stock units vest in full on the anniversary of the February 6, 2026 grant date.
F2. This forfeiture of shares to satisfy applicable tax withholding does not constitute a sale transaction. Pursuant to the award agreement, shares are required to be forfeited to satisfy applicable tax withholding in connection with the vesting of restricted stock units granted on February 7, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Healthpeak Properties (DOC) report for Thomas John T?

Healthpeak Properties director Thomas John T reported routine equity compensation and tax withholding transactions. He received 23,739 common shares on February 6, 2026, then forfeited 6,454 shares on February 7, 2026 to cover tax obligations tied to previously granted restricted stock units.

How many Healthpeak (DOC) shares does Thomas John T own after these transactions?

After the reported transactions, Thomas John T holds 828,668 shares of Healthpeak Properties common stock directly. He also reports 58 additional shares held indirectly, labeled as owned "By Child 7," reflecting a small position attributed to a family member’s account.

Why did Thomas John T forfeit 6,454 Healthpeak (DOC) shares?

The 6,454-share transaction on February 7, 2026 is a forfeiture to satisfy tax withholding on vesting restricted stock units granted February 7, 2025. The footnote clarifies this forfeiture is required under the award agreement and does not constitute a sale transaction in the market.

Were any of Thomas John T’s Healthpeak transactions open-market sales or purchases?

The filing describes a grant of 23,739 shares at a stated price of $0 and a 6,454-share forfeiture for tax withholding. A footnote explicitly states the forfeiture does not constitute a sale transaction, indicating these are compensation and tax-related events rather than market trades.

What roles does Thomas John T hold at Healthpeak Properties (DOC)?

The filing identifies Thomas John T as a director of Healthpeak Properties, Inc. It does not list him as an officer or 10% owner, and no additional roles or titles are specified beyond his board position in the relationship section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/10/2026 - 04:28 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas John T

(Last)

(First)

(Middle)

4600 SOUTH SYRACUSE STREET

SUITE 500

(Street)

DENVER

80237

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/06/2026		A		23,739⁽¹⁾	A	$0	835,122	D
Common Stock	02/07/2026		F		6,454⁽²⁾	D	$16.85	828,668	D
Common Stock								58	I	By Child 7

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units vest in full on the anniversary of the February 6, 2026 grant date.

2. This forfeiture of shares to satisfy applicable tax withholding does not constitute a sale transaction. Pursuant to the award agreement, shares are required to be forfeited to satisfy applicable tax withholding in connection with the vesting of restricted stock units granted on February 7, 2025.

Remarks:

	Carol Samaan, SVP, Legal (Attorney-In-Fact)	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR